These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7849935

  • 1. Oxidative assessment of phospholipid-stabilized perfluorocarbon-based blood substitutes.
    Tarara TE, Malinoff SH, Pelura TJ.
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1287-93. PubMed ID: 7849935
    [Abstract] [Full Text] [Related]

  • 2. Stabilization of perflubron emulsions with egg yolk phospholipid.
    Pelura TJ, Johnson CS, Tarara TE, Weers JG.
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):845-8. PubMed ID: 1391521
    [Abstract] [Full Text] [Related]

  • 3. The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid.
    Putyatina TK, Aprosin UD, Afonin NI.
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1281-5. PubMed ID: 7849934
    [Abstract] [Full Text] [Related]

  • 4. The use of semifluorinated alkanes in blood-substitutes.
    Meinert H, Knoblich A.
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):583-95. PubMed ID: 8117848
    [Abstract] [Full Text] [Related]

  • 5. [Rheological behavior of blood substitutes with a perfluorocarbon base].
    Draffehn J, Reichelt H.
    Pharmazie; 1991 Nov; 46(11):800-2. PubMed ID: 1725823
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the influence of the aqueous phase bioconstituent environment on the F-19 T1 of perfluorocarbon blood substitute emulsions.
    Thomas SR, Pratt RG, Millard RW, Samaratunga RC, Shiferaw Y, Clark LC, Hoffmann RE.
    J Magn Reson Imaging; 1994 Nov; 4(4):631-5. PubMed ID: 7949694
    [Abstract] [Full Text] [Related]

  • 7. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery.
    Riess JG.
    Artif Cells Blood Substit Immobil Biotechnol; 2005 Nov; 33(1):47-63. PubMed ID: 15768565
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of buffer pH and phosphate concentration on the droplet size and EYP hydrolysis of perflubron/EYP emulsions.
    Song D, Pelura TJ, Liu J, Ni Y.
    Artif Cells Blood Substit Immobil Biotechnol; 1994 Nov; 22(4):1299-305. PubMed ID: 7849937
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of formulation, processing and storage parameters on the characteristics and stability of perflubron emulsion.
    Ni Y, Pelura TJ, Sklenar TA, Kinner RA, Song D.
    Artif Cells Blood Substit Immobil Biotechnol; 1994 Nov; 22(4):1307-15. PubMed ID: 7849938
    [Abstract] [Full Text] [Related]

  • 13. Oxygen solubility, rheology and hemodynamics of perfluorocarbon emulsion blood substitutes.
    Millard RW.
    Artif Cells Blood Substit Immobil Biotechnol; 1994 Nov; 22(2):235-44. PubMed ID: 8087245
    [Abstract] [Full Text] [Related]

  • 14. Fluorocarbon emulsions--the stability issue.
    Postel M, Riess JG, Weers JG.
    Artif Cells Blood Substit Immobil Biotechnol; 1994 Nov; 22(4):991-1005. PubMed ID: 7849970
    [Abstract] [Full Text] [Related]

  • 15. In vitro model to compare the oxygen offloading behaviour of dodecafluoropentane emulsion (DDFPe).
    Jayaraman MS, Graham K, Unger EC.
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):783-789. PubMed ID: 30873883
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.